Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 345

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 345
---
Equity Incentive Plan Awards: Number of Unearned Unvested Shares  
     Equity Incentive Plan Awards: Market or Payout Value of Unearned Unvested Shares 

    Francis Knuettel II, Chief Executive Officer and Chief Financial Officer 
     17,778  
     4,445  
     —  
    $22.68  
    09/30/2032 
     —  
    $—  
     —  
    $— 

    Francis Knuettel II, Chief Executive Officer and Chief Financial Officer 
     2,778  
     —  
     —  
     22.68  
    1/10/2033 
     —  
     —  
     —  
     — 

    Francis Knuettel II, Chief Executive Officer and Chief Financial Officer 
     27,778  
     —  
     —  
     22.68  
    5/15/2033 
     —  
     —  
     —  
     — 

    Francis Knuettel II, Chief Executive Officer and Chief Financial Officer 
     81,000  
     243,000  
     —  
     1.30  
    6/14/2024 
     —  
     —  
     —  
     — 

    Eric Lang, Chief Medical Officer 
     10,093  
     14,130  
     —  
    $22.68  
    5/15/2033 
     —  
    $—  
     —  
    $— 

    Eric Lang, Chief Medical Officer 
     32,500  
     97,500  
     —  
     1.30  
    6/14/2034 
     —  
     —  
     —  
     — 

92 

Equity
Incentive Plans

The
Channel Therapeutics Corporation 2023 Equity Incentive Plan

On
January 10, 2023, our board of directors adopted and submitted for stockholder approval the 2023 Plan, which 2023 Plan was later
approved by the Company’s stockholders